Astellas constitutes a reference in the areas of Transplantation, Urology and Anti-infectives, a position we have achieved to extend it to Oncology, thanks to our commitment to innovation.

With approximately 20% of our sales earmarked for research, we aim to build a strong presence in therapeutic areas where a large number of unmet medical needs still exist.

Currently we have 12 different molecules in clinical development phase in Oncology. Through these research programs, we aspire to change the tomorrow of patients suffering from solid tumors such as Prostate Cancer and others in close future, or haematologic malignancies.


Learn more about our therapeutic areas: